BTG International

London, United Kingdom Founded: 1948 • Age: 78 yrs Acquired By Boston Scientific
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.

About BTG International

BTG International is a company based in London (United Kingdom) founded in 1948 was acquired by Boston Scientific in November 2018.. The company has 1 employees as of December 31, 2021. BTG International has completed 7 acquisitions, including Biocompatibles, EKOS Corporation and Galil Medical. BTG International offers products and services including Defibrillators, Pacemakers, and Spinal Cord Stimulators. BTG International operates in a competitive market with competitors including Pulnovo Medical, SoniVie, Aria CV, Bellerophon Therapeutics and Adient Medical, among others.

  • Headquarter London, United Kingdom
  • Employees 1 as on 31 Dec, 2021
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Btg International Limited
  • Date of Incorporation 14 Nov, 1991
  • Jurisdiction FARNHAM, SURREY
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $173.79 M (USD)
    7
    as on Dec 31, 2020
  • Net Profit
    $58.14 M (USD)
    11
    as on Dec 31, 2020
  • EBITDA
  • Latest Funding Round
    $5.5 M (USD), Post-IPO

    Jan 28, 2011

  • Investors
  • Employee Count
    1

    as on Dec 31, 2021

  • Investments & Acquisitions
  • Acquired by
    Boston Scientific

    (Nov 20, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BTG International

BTG International offers a comprehensive portfolio of products and services, including Defibrillators, Pacemakers, and Spinal Cord Stimulators. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Devices that treat cardiac arrhythmias and save lives.

Implants that regulate heart rhythm for patients.

Systems that alleviate chronic pain through stimulation.

People of BTG International
Headcount 10000+
Employee Profiles 1142
Board Members and Advisors 9
Employee Profiles
People
Genevieve Morrison
IT Director, Acquisition & Integrations
People
Rosaleen Burke
SVP, Global Quality & Regulatory
People
Wendy Ureña Castillo
Sr. Supplier Engineer
People
Suzanne Boyum
Sr. Business Process Analyst - Global Supply Chain COE

Unlock access to complete

Board Members and Advisors
people
John E. Sununu
Director
people
Yoshiaki Fujimori
Director
people
Ellen M. Zane
Director
people
David S. Wichmann
Director

Unlock access to complete

Funding Insights of BTG International

  • Total Funding
  • Total Rounds 6
  • Last Round Post-IPO — $5.5M
  • First Round

    (15 May 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2011 Amount Post-IPO - BTG International Valuation

investors

Jan, 2011 Amount Grant - BTG International Valuation

investors

HHS
Jan, 2011 Amount Grant - BTG International Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BTG International

BTG International has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Boston Scientific and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Wide range of medical devices
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BTG International

BTG International has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Biocompatibles, EKOS Corporation and Galil Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Catheters for interventional cardiology in arterial disease are developed.
2011
Obstetric device developed to prevent childbirth infections.
2010
Inferior vena cava filters are developed for pulmonary embolism treatment.
2006
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - BTG International

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Btg International Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BTG International

BTG International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulnovo Medical, SoniVie, Aria CV, Bellerophon Therapeutics and Adient Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A medical device for pulmonary hypertension treatment is developed.
domain founded_year HQ Location
A denervation catheter for pulmonary hypertension treatment is developed.
domain founded_year HQ Location
Device for pulmonary hypertension
domain founded_year HQ Location
Drug-device therapies for pulmonary hypertension are developed.
domain founded_year HQ Location
Bioabsorbable medical devices are developed for pulmonary embolism prevention.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Btg International

Frequently Asked Questions about BTG International

When was BTG International founded?

BTG International was founded in 1948 and raised its 1st funding round 60 years after it was founded.

Where is BTG International located?

BTG International is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

How many employees does BTG International have?

As of Dec 31, 2021, the latest employee count at BTG International is 1.

What is the annual revenue of BTG International?

Annual revenue of BTG International is $173.79M as on Dec 31, 2020.

What does BTG International do?

BTG International was founded in 1948 in London, United Kingdom, within the pharmaceuticals sector. Therapeutic agents are developed for disorders including neurological conditions, varicose veins, liver cancer, blood clots, and emphysema. Operations span three segments: Interventional Medicine, covering oncology products like TheraSphere, vascular treatments such as Varithena, and pulmonology options like PneumRx Coil. Antidote products, including CroFab for snake envenomations and DigiFab for digoxin toxicity, are also provided.

Who are the top competitors of BTG International?

BTG International's top competitors include Pulnovo Medical, SoniVie and Corflow.

What products or services does BTG International offer?

BTG International offers Defibrillators, Pacemakers, and Spinal Cord Stimulators.

How many acquisitions has BTG International made?

BTG International has made 7 acquisitions, including Biocompatibles, EKOS Corporation, and Galil Medical.

Who are BTG International's investors?

BTG International has 2 investors. Key investors include Boston Scientific, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available